ADAM17 and Alzheimer disease: In conclusion, our study identifies a reduced expression of microvascular ADAM17 as a novel mechanism by which microvascular dysfunction occurs in an AD mouse model and by which it could contribute to the development of cognitive decline and memory deficits.